Drug Discovery World

AUGUST 29, 2024

HTS compatible cellular assays Robert G Lowery PhD, President & CEO at BellBrook Labs, comments: “AI and virtual screening are increasing the diversity of targets in drug discovery, but developing virtual hits still requires wet biology, using technologies developed over the last 25 years.

Small Molecule 147

Small Molecule Drugs Protein Expression Assay Development 147

Drug Discovery World

DECEMBER 28, 2022

The introduction of plug and play kits is designed to increase the utility of the platform by removing the timelines needed for assay development. . Scipio bioscience’s single-cell RNA-seq solution includes the Asteria Benchtop Kit and the Cytonaut Cloud Analysis Software. . The deadline for applications is January 31, 2023.

Production 242

Production Compliance Assay Development RNA 242

Broad Institute

JUNE 30, 2023

LipocyteProfiler builds on the concept of image-based profiling that was first introduced in the context of morphology mapping by Cell Painting, a high-content imaging assay developed by Broad institute scientist and Imaging Platform senior director Anne Carpenter. Online June 20, 2023. Papers cited Laber S, Strobel SM, et al.

Small Molecule 105

Small Molecule Cell Based Assays Disease Assay Development 105

Elrig

APRIL 29, 2024

Harini joined Serna Bio in early 2021 and has been an integral part of the multidisciplinary teamworking on target ID platform development to drug discovery. She has played a key role inbuilding the target identification platform and a proprietary database of transcriptome-wide, functional RNA structures.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59